• About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Menu
  • About Us
    • Careers
  • M&A Services
    • Buy Side Advisory
    • Capital Raising
    • Sell Side Advisory
    • Transaction Planning & Readiness Review
  • Industry Expertise
    • Business Services & Technology
    • Consumer, Food & Retail
    • Healthcare
    • Industrials
    • Plastics & Packaging
  • Transactions
  • Team
  • News & Insights
    • Events
    • Industry Updates
    • News
    • Perspectives
Contact

Industry Updates

  • Back to News & Insights

Medical Technology M&A Pulse – Q3 2021

  • November 30, 2021
  • Industry Updates
  • Healthcare, Medical Technology
2021 Q3: Markets Continue to Shine
  • Despite headwinds from an uptick in COVID-19 cases due to the surge of the delta variant, the third quarter continued 2021’s trend of robust M&A activity and strong public equity performance across sectors. Investors in both the private and public markets remain bullish, with early Q4 signs indicating that strong performance will continue, ending the year on a high note.
  • Total announced M&A transactions in Q3 took a slight step back from Q2’s record highs, but remained strong, up 17% over Q3 of 2020, and 21% from 2020’s quarterly average. With potential changes to capital gains tax rates still a possibility, business owners continue to aggressively seek to pursue sale transactions. This, paired with significant acquisition interest from both private equity investors as well as strategic acquirers has led to both the active transaction market as well as attractive valuations for sellers across sectors.
  • During the year to date, PMCF’s four Medical Technology indices have all seen solid growth, though they were buffeted by a market wide sell-off at the end of the third quarter. Cardiovascular Medical Devices was the strongest performing sector through three quarters, up 12.8% on the year, just above the Dow Jones Industrial Average, which closed up 12.0% and behind the benchmark S&P 500 Growth Index which finished up 17.6%.

 

Read Medical Technology M&A Pulse Q3 2021 Full Report

Download Preview

Stay Informed

Subscribe to our newsletter for the latest industry updates

Subscribe

Recent Publications

Packaging M&A Update – May 2022
Plastics M&A Update – May 2022
Industrial Distributor M&A Pulse – Q1 2022
Software & Technology M&A Pulse – Q1 2022
Plastics M&A Update – April 2022
Contact

Follow Us On

Securities offered through P&M Corporate Finance, LLC. Member of FINRA and SIPC.

Cfi Logo White 94x94 On About

Home

  • About
  • Team
  • Careers

M&A Services

  • Buy Side Advisory
  • Capital Raising
  • Sell Side Advisory
  • Transaction Planning & Readiness Review

Industry Expertise

  • Business Services & Technology
  • Consumer, Food & Retail
  • Healthcare
  • Industrials
  • Plastics & Packaging

News & Insights

  • Transactions
  • News
  • Industry Updates
  • Perspectives
  • Events

©2021 PMCF

  • Member SIPC​
  • Member FINRA
  • FINRA Broker Check
  • Business Continuity Plan​
  • Disclaimer​
  • Privacy Policy​
Cookie Notice: This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our Privacy Policy for more information on the cookies we use.AgreePrivacy policy